Drug Pricing & Manufacturing: Nine mid-sized drugmakers struck White House deals to join CMS’s GENEROUS model Medicaid pricing and avoid certain tariffs, with pledges to boost U.S. manufacturing and supply. MS Pipeline: Novartis reported Phase 3 success for remibrutinib in multiple sclerosis, showing lower relapse rates and inflammatory lesions versus Aubagio, with no new liver-safety concerns. AI in Clinical Care: OpenAI is integrating ChatGPT Health with Epic EHRs for read-only clinician access and pre-visit summaries, plus a public-data plugin for trial and coverage lookups. Regenerative Medicine: R3 Stem Cell landed on CIO Bulletin’s 2026 best regenerative medicine and stem cell training lists. Maternal Health: Delaware signed a law requiring hospital discharge plans for pregnant patients seeking labor-symptom care, aiming to reduce gaps that hit Black patients hardest. Local Health Systems: Sanford Health and North Memorial Health finalized a partnership into one integrated nonprofit system in Minnesota. Care Access & Fraud: A judge blocked most of Virginia’s new law limiting cooperation with ICE while health-related coverage disputes continue to surface, including investigations into TRICARE contractor claim denials. Public Health Alerts: Utah warned schools and families about mislabeled “Cat’s Claw” products linked to opioid-acting compounds and overdoses. Wellness & Scams: New guidance urges consumers to watch for deceptive weight-loss and health claims.